Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joshua Field, MD, MS
Medical College of Wisconsin
Principal Investigator - Michael R. DeBaun, MD, MPH
Vanderbilt University Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2013
- Primary completion
- 31 Mar 2018
- Completion
- 31 Mar 2018
- Last update posted
- 26 Mar 2019
- Registered enrollment
- 46
- Registry id
- NCT01960413
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.